Outperformance and 10 Changes for the Model Shadow Stock Portfolio
The model portfolio’s quarterly review results in five deletions and five additions.
John Bajkowski
Stock Evaluator: USANA Health Sciences, Inc. (USNA)
USANA Health Sciences, Inc. USNA
$14.76
0.20
1.37%
September 3, 2026 9:41:14 AM
EST
Volume: 5,874
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Staples | Personal Care Products |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Commentary & Analysis
3 Undervalued Personal Care Products Stocks for Wednesday, May 27
Discover the top 3 undervalued Personal Care Products stocks for Wednesday, May 27 based on AAII’s Stock Grades.Rosalio Madrigal
Why USANA Health Sciences, Inc.’s (USNA) Stock Is Up 5.81%
As of Wednesday, May 27, USANA Health Sciences, Inc.’s USNA share price has surged by 5.81%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why USANA Health Sciences, Inc.’s (USNA) Stock Is Down 5.91%
As of Monday, May 11, USANA Health Sciences, Inc.’s USNA share price has dipped by 5.91%, which has investors questioning if this is right time to buy.Jenna Brashear
What You Need to Know About USANA Health Sciences, Inc.'s Q2 Earnings
USANA Health Sciences, Inc.'s fiscal Q2 earnings report was released on Tuesday, May 05. Let's dive in to see if (USNA) missed or beat analyst's expectations.Jenna Brashear
Financial Summary
| Share Statistics | USNA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $269.0 | $250.3 | 30% |
|
| Shares Out (Mil) | 18.5 | 32.8 | 29% |
|
| Institutional Ownership | 58.3% | 58.3% | 38% |
|
| Float (Mil) | 9.9 | 37.8 | 19% |
|
| Beta | 0.68 | 0.56 | 40% |
|
| Avg Daily Volume (000s) | 209 | 114 | 46% |
|
| Price Change (52-week) |
(54.0%) | 57.2% | 13% |
|
| Growth | USNA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (4.0%) | 0.9% | 10% |
|
| Net Income (5yr) | (38.7%) | (7.5%) | 10% |
|
| EPS (5yr) | (37.0%) | (0.2%) | 6 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.5%) | (14.9%) | 37% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.110 | $0.760 | $1.770 | |
| Month Ago EPS | $0.430 | $2.120 | $2.770 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 2 | 0 | |
| Three Months Ago EPS | $0.430 | $2.120 | $2.770 | |
| Year/Year Chg | (109.5%) | 31.0% | na | |
| Financials | USNA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $913 | $571 | 49% |
|
| Net Income (TTM) (Mil) | ($22) | ($1) | 23% |
|
| EPS (TTM) | ($1.207) | $0.000 | 19% |
|
| Operating Cash Flow (TTM) (Mil) | $28 | $25 | 43% |
|
| Net Cash Flow (TTM) (Mil) | $17 | $1 | 61% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $42 | 0% |
|
| Enterprise Value (Q1) (Mil) | $134 | $346 | 23% |
|
| Valuation | USNA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.51 | 2.00 | 8% |
|
| P/E | na | 16.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.6 | na |
|
| Ratios | USNA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 77.4% | 62.9% | 87% |
|
| Net Margin | (2.4%) | 1.2% | 28% |
|
| ROA | (3.1%) | (1.5%) | 32% |
|
| ROE | (4.2%) | 4.8% | 32% |
|
| Liabilities to Assets | 18.8% | 49.5% | 12% |
|
| F-Score | 4 | 4 | 33% |
|
USANA Health Sciences, Inc. did not pass any screens on 9/2/2026.
